Supplementation with concentrated milk protein in patients undergoing hematopoietic stem cell transplantation

WPC intake ≥40% of DPR helped to reduce the severity and duration of OM. The use of WPC in patients undergoing HSCT was shown to be safe, encouraging new studies in this population to assess its action mechanism.